AstraZeneca PLC is 168.6x more valuable than Innoviva, Inc. by market capitalization ($286.27 B vs $1.70 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INVA | AZN |
|---|---|---|
| Market cap | $1.70 B | $286.27 B |
| US-listed rank | #2220 | #45 |
| Revenue (latest FY) | $411.33M | - |
| SEC filings | 1,653 | 1,002 |
AstraZeneca PLC is 168.6x more valuable than Innoviva, Inc. by market capitalization ($286.27 B vs $1.70 B).
Full pages: Innoviva, Inc. and AstraZeneca PLC, or browse the full rankings.